Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dr. Mefloquine‐Induced Eosinophilic Pneumonia

Identifieur interne : 001B54 ( Main/Exploration ); précédent : 001B53; suivant : 001B55

Dr. Mefloquine‐Induced Eosinophilic Pneumonia

Auteurs : Stamatis Katsenos [Grèce] ; Kostas Psathakis [Grèce] ; Melita I. Nikolopoulou [Grèce] ; Stavros H. Constantopoulos [Grèce]

Source :

RBID : ISTEX:0DEDED71FB1F81C0DA98063D80D3234424FF009A

English descriptors

Abstract

Mefloquine has been widely used for prophylaxis and treatment of patients with chloroquine‐resistant malaria; the drug is usually well tolerated. Rarely, adverse effects may be severe, including gastrointestinal disturbances, neuropsychiatric reactions, cardiovascular manifestations, skin lesions, musculoskeletal symptoms, and bone marrow toxicity. We describe a 67‐year‐old woman with fever, dyspnea on exertion, peripheral blood eosinophilia, and diffuse pulmonary infiltrates on chest radiography. She had taken mefloquine for malaria prophylaxis for an 8‐week trip to South Africa. A thorough work‐up led to the diagnosis of eosinophilic pneumonia caused by the mefloquine. Her condition improved after the drug was discontinued. To our knowledge, this is the first report of mefloquine‐induced eosinophilic pneumonia. Clinicians should be aware of this rare, potential adverse effect of mefloquine.

Url:
DOI: 10.1592/phco.27.12.1767


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dr. Mefloquine‐Induced Eosinophilic Pneumonia</title>
<author>
<name sortKey="Katsenos, Stamatis" sort="Katsenos, Stamatis" uniqKey="Katsenos S" first="Stamatis" last="Katsenos">Stamatis Katsenos</name>
</author>
<author>
<name sortKey="Psathakis, Kostas" sort="Psathakis, Kostas" uniqKey="Psathakis K" first="Kostas" last="Psathakis">Kostas Psathakis</name>
</author>
<author>
<name sortKey="Nikolopoulou, Melita I" sort="Nikolopoulou, Melita I" uniqKey="Nikolopoulou M" first="Melita I." last="Nikolopoulou">Melita I. Nikolopoulou</name>
</author>
<author>
<name sortKey="Constantopoulos, Stavros H" sort="Constantopoulos, Stavros H" uniqKey="Constantopoulos S" first="Stavros H." last="Constantopoulos">Stavros H. Constantopoulos</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0DEDED71FB1F81C0DA98063D80D3234424FF009A</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1592/phco.27.12.1767</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-SKDRQDJR-D/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000944</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000944</idno>
<idno type="wicri:Area/Istex/Curation">000944</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A37</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A37</idno>
<idno type="wicri:doubleKey">0277-0008:2007:Katsenos S:dr:mefloquine:induced</idno>
<idno type="wicri:Area/Main/Merge">001B65</idno>
<idno type="wicri:Area/Main/Curation">001B54</idno>
<idno type="wicri:Area/Main/Exploration">001B54</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Dr. Mefloquine‐Induced Eosinophilic Pneumonia</title>
<author>
<name sortKey="Katsenos, Stamatis" sort="Katsenos, Stamatis" uniqKey="Katsenos S" first="Stamatis" last="Katsenos">Stamatis Katsenos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pneumonology, University Hospital, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Grèce</country>
</affiliation>
</author>
<author>
<name sortKey="Psathakis, Kostas" sort="Psathakis, Kostas" uniqKey="Psathakis K" first="Kostas" last="Psathakis">Kostas Psathakis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pneumonology, Army General Hospital, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nikolopoulou, Melita I" sort="Nikolopoulou, Melita I" uniqKey="Nikolopoulou M" first="Melita I." last="Nikolopoulou">Melita I. Nikolopoulou</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pneumonology, Army General Hospital, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Constantopoulos, Stavros H" sort="Constantopoulos, Stavros H" uniqKey="Constantopoulos S" first="Stavros H." last="Constantopoulos">Stavros H. Constantopoulos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pneumonology, University Hospital, Ioannina</wicri:regionArea>
<wicri:noRegion>Ioannina</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</title>
<title level="j" type="alt">PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY</title>
<idno type="ISSN">0277-0008</idno>
<idno type="eISSN">1875-9114</idno>
<imprint>
<biblScope unit="vol">27</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1767">1767</biblScope>
<biblScope unit="page" to="1771">1771</biblScope>
<biblScope unit="page-count">5</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2007-12">2007-12</date>
</imprint>
<idno type="ISSN">0277-0008</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0277-0008</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Alveolar macrophages</term>
<term>Aminobutyric acid release</term>
<term>Antimalarial</term>
<term>Antimalarial agent</term>
<term>Arterial blood gases</term>
<term>Bronchoalveolar lavage</term>
<term>Chest radiography</term>
<term>Clin</term>
<term>Eosinophil</term>
<term>Eosinophilia</term>
<term>Eosinophilic</term>
<term>Eosinophilic lung disease</term>
<term>Eosinophilic pneumonia</term>
<term>Eosinophilic pneumonia katsenos</term>
<term>Infiltrates</term>
<term>Katsenos</term>
<term>Ketoconazole</term>
<term>Malaria prophylaxis</term>
<term>Mefloquine</term>
<term>Musculoskeletal manifestations</term>
<term>Oral mefloquine</term>
<term>Partial pressure</term>
<term>Peripheral blood eosinophilia</term>
<term>Pharmacotherapy volume</term>
<term>Plasmodium</term>
<term>Pneumonia</term>
<term>Prophylaxis</term>
<term>Pulmonary eosinophilia</term>
<term>Pulmonary toxicity</term>
<term>Radiography</term>
<term>Subpleural infiltrates</term>
<term>Tomography</term>
<term>Tomography scan</term>
<term>Topical ketoconazole</term>
<term>Toxicity</term>
<term>University hospital</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mefloquine has been widely used for prophylaxis and treatment of patients with chloroquine‐resistant malaria; the drug is usually well tolerated. Rarely, adverse effects may be severe, including gastrointestinal disturbances, neuropsychiatric reactions, cardiovascular manifestations, skin lesions, musculoskeletal symptoms, and bone marrow toxicity. We describe a 67‐year‐old woman with fever, dyspnea on exertion, peripheral blood eosinophilia, and diffuse pulmonary infiltrates on chest radiography. She had taken mefloquine for malaria prophylaxis for an 8‐week trip to South Africa. A thorough work‐up led to the diagnosis of eosinophilic pneumonia caused by the mefloquine. Her condition improved after the drug was discontinued. To our knowledge, this is the first report of mefloquine‐induced eosinophilic pneumonia. Clinicians should be aware of this rare, potential adverse effect of mefloquine.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Grèce</li>
</country>
<region>
<li>Attique (région)</li>
</region>
<settlement>
<li>Athènes</li>
</settlement>
</list>
<tree>
<country name="Grèce">
<noRegion>
<name sortKey="Katsenos, Stamatis" sort="Katsenos, Stamatis" uniqKey="Katsenos S" first="Stamatis" last="Katsenos">Stamatis Katsenos</name>
</noRegion>
<name sortKey="Constantopoulos, Stavros H" sort="Constantopoulos, Stavros H" uniqKey="Constantopoulos S" first="Stavros H." last="Constantopoulos">Stavros H. Constantopoulos</name>
<name sortKey="Katsenos, Stamatis" sort="Katsenos, Stamatis" uniqKey="Katsenos S" first="Stamatis" last="Katsenos">Stamatis Katsenos</name>
<name sortKey="Nikolopoulou, Melita I" sort="Nikolopoulou, Melita I" uniqKey="Nikolopoulou M" first="Melita I." last="Nikolopoulou">Melita I. Nikolopoulou</name>
<name sortKey="Psathakis, Kostas" sort="Psathakis, Kostas" uniqKey="Psathakis K" first="Kostas" last="Psathakis">Kostas Psathakis</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B54 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B54 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:0DEDED71FB1F81C0DA98063D80D3234424FF009A
   |texte=   Dr. Mefloquine‐Induced Eosinophilic Pneumonia
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021